Skip to main content

Armistice Capital, LLC's Form 4 filing

Avalo Therapeutics, Inc.AVTX · filed Feb 9, 2023

Accession no.
0000899243-23-004412
Filed
Feb 9, 2023, 4:32 PM ET
Trade date
Feb 3-7, 2023
Filing delay
6 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions and 1 derivative transaction. It was filed 6 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Armistice Capital, LLCCIK 000160108610% Owner
Armistice Capital Master Fund Ltd.CIK 000163358410% Owner
Boyd StevenCIK 000170614010% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 3, 2023Common StockLLess common codeAcquired+334$3.95+$1,319.33,965,000Indirect
Feb 7, 2023Common StockPPurchaseAcquired+450,000–F3–4,415,000Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 7, 2023Common StockPPurchaseAcquired+450,000–F4–450,000Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

Each share of common stock and accompanying warrant were purchased together for $3.98. The warrants are subject to a 4.99% beneficial ownership limitation on exercise.

Referenced by the price of 1 transaction in Table I.

F4

These shares are directly owned by Mr. Boyd in his personal capacity.

Referenced by the price of 1 transaction in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)